Dare Bioscience Inc
NASDAQ:DARE

Watchlist Manager
Dare Bioscience Inc Logo
Dare Bioscience Inc
NASDAQ:DARE
Watchlist
Price: 2.515 USD 5.23% Market Closed
Market Cap: 22.3m USD

Wall Street
Price Targets

DARE Price Targets Summary
Dare Bioscience Inc

Wall Street analysts forecast DARE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DARE is 13.26 USD with a low forecast of 12.12 USD and a high forecast of 14.7 USD.

Lowest
Price Target
12.12 USD
382% Upside
Average
Price Target
13.26 USD
427% Upside
Highest
Price Target
14.7 USD
484% Upside
Dare Bioscience Inc Competitors:
Price Targets
603566
Pulike Biological Engineering Inc
11% Upside
002653
Haisco Pharmaceutical Group Co Ltd
37% Upside
CRMD
CorMedix Inc
49% Upside
688513
Chengdu Easton Biopharmaceuticals Co Ltd
7% Upside
002262
Jiangsu Nhwa Pharmaceutical Co Ltd
48% Upside
4577
Daito Pharmaceutical Co Ltd
4% Downside
INDV
Indivior PLC
1% Upside
CONCORDBIO
Concord Biotech Ltd
7% Upside

Revenue
Forecast

Revenue Estimate
Dare Bioscience Inc

The compound annual growth rate of Dare Bioscience Inc's revenue for the next 3 years is 1 840%.

N/A
Past Growth
1 840%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Dare Bioscience Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
Dare Bioscience Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-57%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DARE's stock price target?
Price Target
13.26 USD

According to Wall Street analysts, the average 1-year price target for DARE is 13.26 USD with a low forecast of 12.12 USD and a high forecast of 14.7 USD.

What is Dare Bioscience Inc's Revenue forecast?
Projected CAGR
1 840%

The compound annual growth rate of Dare Bioscience Inc's revenue for the next 3 years is 1 840%.

Back to Top